Captrust Financial Advisors Oramed Pharmaceuticals Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.19 - $13.89 $745 - $1,263	-91 Reduced 59.87%	61 $1,000
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $402 - $922	31 Added 25.62%	152 $2,000
Q3 2021 Nov 16, 2021	BUY	$12.13 - $23.82 $861 - $1,691	71 Added 142.0%	121 $3,000
Q2 2021 Aug 16, 2021	BUY	$8.34 - $14.59 $417 - $729	50 New	50 $1,000

6.37M

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $93.6M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.